Profil
Luis Voloch was associated with Immunai, Inc. as the Chief Technology Officer.
He is also the founder of Immunai, Inc. which was founded in 2018.
Anciens postes connus de Luis Voloch
| Sociétés | Poste | Fin |
|---|---|---|
Immunai, Inc.
 Immunai, Inc. Packaged SoftwareTechnology Services Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY. | Fondateur | 01/12/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Immunai, Inc.
Immunai, Inc. Packaged SoftwareTechnology Services Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY. | Technology Services |
